ENTITY

Zai Lab (9688 HK)

58
Analysis
Health Care • China
Zai Lab is an innovative, research-based, commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative products for oncology, immunology, neuroscience, and infectious diseases. The company has commercialized products such as Zejula, Optune, Qinlock, Nuzyra, and Vyvgart in China. Zai Lab was founded in 2014 and is headquartered in Shanghai, China, and Cambridge, Massachusetts, USA.
more
Company Presentation • 06 Aug 2026 20:00

Q2 2026

Company Presentation • 07 May 2026 20:00

Q1 2026

Company Presentation • 20 Apr 2026 20:30

Study update

Company Presentation • 10 Jan 2022 22:00

JPMorgan 40th Annual Healthcare Conference

Company Presentation • 26 Feb 2026 21:00

Q4 2025

x